文献速递皮肤肿瘤皮肤感染

免疫相关皮肤癌患者第二原发癌风险的双向研究

Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma: Role for Immune Mechanisms?
PubMed 文献 · J Invest Dermatol · 2019-07-06

基于瑞典癌症登记1958至2015年数据,评估侵袭性和原位皮肤鳞状细胞癌、卡波西肉瘤及默克尔细胞癌与第二原发癌的双向关联。研究发现26种癌症与侵袭性皮肤癌存在双向风险增加,Spearman秩相关系数为0.72(P=4.6×10-5),提示免疫抑制可能是第二原发癌风险增加的关键机制。

要点

  • 免疫相关皮肤癌与多种癌症存在双向风险增加,支持免疫抑制机制。
  • 卡波西肉瘤后第二原位皮肤鳞癌风险达685.68,默克尔细胞癌后为117.23。
  • 侵袭性和原位皮肤鳞癌作为第二原发癌的相对风险分别为14.59和16.71。

核心结论

  • 免疫相关皮肤癌与大多数其他癌症之间存在高度系统性的双向风险,提示免疫抑制是第二原发癌风险增加的关键机制。

研究设计与样本

  • 基于瑞典癌症登记1958至2015年数据的双向标准化相对风险计算,侵袭性和原位皮肤鳞状细胞癌各识别超过80,000例第一原发癌。

主要发现

  • 侵袭性皮肤癌相关的26种癌症存在双向风险增加,Spearman秩相关系数为0.72(P=4.6×10-5)。
  • 侵袭性和原位皮肤癌作为第二原发癌的相对风险分别为14.59和16.71。
  • 卡波西肉瘤后第二原位皮肤鳞癌风险为685.68,默克尔细胞癌后为117.23。

临床怎么用

  • 对免疫相关皮肤癌患者应关注第二原发癌的筛查与监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Second primary cancers (SPCs) are becoming a common cancer entity, which may interfere with survival in relatively benign first primary cancers. We examined the hypothesis that immune dysfunction may contribute to SPCs by assessing SPCs associated with known immune responsive skin cancers, invasive and in situ squamous cell carcinoma, Kaposi sarcoma, and Merkel cell carcinoma. Cancers were identified from the Swedish Cancer Registry from the year 1958 to 2015. Standardized relative risks were calculated bidirectionally for any SPC after skin cancer and for skin cancer as SPC. Over 80,000 first primary cancers were identified for each invasive and in situ squamous cell carcinoma of the skin. Bidirectional increased risks were observed for 26 cancers associated with invasive skin cancer; the Spearman rank correlation was 0.72 (P = 4.6 × 10-5). The highest bidirectional relative risks were for invasive and in situ skin cancer as SPCs (14.59 and 16.71, respectively). Remarkably high risks for second in situ squamous cell carcinoma of the skin were found after Kaposi sarcoma (685.68) and Merkel cell carcinoma (117.23). The high systematic bidirectional risks between immune responsive skin cancers and most other cancers suggest that immune suppression is a key mechanism contributing to an increased risk of SPCs.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Chattopadhyay S, Hemminki A, Försti A, et al. Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma: Role for Immune Mechanisms? J Invest Dermatol. 2019. PMID: 31288011. doi:10.1016/j.jid.2019.04.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。